GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » MedAvail Holdings Inc (OTCPK:MDVLQ) » Definitions » Beneish M-Score

MedAvail Holdings (MedAvail Holdings) Beneish M-Score : -4.01 (As of Apr. 29, 2024)


View and export this data going back to 2020. Start your Free Trial

What is MedAvail Holdings Beneish M-Score?

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Good Sign:

Beneish M-Score -4.01 no higher than -1.78, which implies that the company is unlikely to be a manipulator.

The historical rank and industry rank for MedAvail Holdings's Beneish M-Score or its related term are showing as below:

MDVLQ' s Beneish M-Score Range Over the Past 10 Years
Min: -4.17   Med: -1.66   Max: 22.64
Current: -4.01

During the past 4 years, the highest Beneish M-Score of MedAvail Holdings was 22.64. The lowest was -4.17. And the median was -1.66.


MedAvail Holdings Beneish M-Score Historical Data

The historical data trend for MedAvail Holdings's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

MedAvail Holdings Beneish M-Score Chart

MedAvail Holdings Annual Data
Trend Dec19 Dec20 Dec21 Dec22
Beneish M-Score
- - 13.36 -2.32

MedAvail Holdings Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 11.03 -1.66 -2.32 -4.17 -4.01

Competitive Comparison of MedAvail Holdings's Beneish M-Score

For the Pharmaceutical Retailers subindustry, MedAvail Holdings's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


MedAvail Holdings's Beneish M-Score Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, MedAvail Holdings's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where MedAvail Holdings's Beneish M-Score falls into.



MedAvail Holdings Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of MedAvail Holdings for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 0.0819+0.528 * 0.177+0.404 * 0.8168+0.892 * 1.7173+0.115 * 0.3116
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 0.5406+4.679 * -0.206734-0.327 * 0.5474
=-4.01

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Jun23) TTM:Last Year (Jun22) TTM:
Total Receivables was $0.29 Mil.
Revenue was 0.405 + 0.62 + 11.35 + 11.461 = $23.84 Mil.
Gross Profit was 0.178 + 0.257 + -0.126 + 1.292 = $1.60 Mil.
Total Current Assets was $27.05 Mil.
Total Assets was $29.91 Mil.
Property, Plant and Equipment(Net PPE) was $1.43 Mil.
Depreciation, Depletion and Amortization(DDA) was $4.72 Mil.
Selling, General, & Admin. Expense(SGA) was $28.30 Mil.
Total Current Liabilities was $4.16 Mil.
Long-Term Debt & Capital Lease Obligation was $2.06 Mil.
Net Income was -5.791 + -17.33 + -11.07 + -11.806 = $-46.00 Mil.
Non Operating Income was -0.896 + -7.379 + 0 + 0 = $-8.28 Mil.
Cash Flow from Operations was -4.379 + -5.21 + -10.381 + -11.569 = $-31.54 Mil.
Total Receivables was $2.08 Mil.
Revenue was 0.543 + 0.265 + 7.28 + 5.792 = $13.88 Mil.
Gross Profit was 0.207 + 0.134 + -0.362 + 0.186 = $0.17 Mil.
Total Current Assets was $40.95 Mil.
Total Assets was $52.83 Mil.
Property, Plant and Equipment(Net PPE) was $8.80 Mil.
Depreciation, Depletion and Amortization(DDA) was $2.76 Mil.
Selling, General, & Admin. Expense(SGA) was $30.48 Mil.
Total Current Liabilities was $8.45 Mil.
Long-Term Debt & Capital Lease Obligation was $11.60 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(0.292 / 23.836) / (2.076 / 13.88)
=0.01225 / 0.149568
=0.0819

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(0.165 / 13.88) / (1.601 / 23.836)
=0.011888 / 0.067167
=0.177

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (27.049 + 1.433) / 29.908) / (1 - (40.95 + 8.799) / 52.833)
=0.04768 / 0.058373
=0.8168

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=23.836 / 13.88
=1.7173

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(2.763 / (2.763 + 8.799)) / (4.718 / (4.718 + 1.433))
=0.238972 / 0.76703
=0.3116

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(28.296 / 23.836) / (30.477 / 13.88)
=1.187112 / 2.195749
=0.5406

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((2.056 + 4.156) / 29.908) / ((11.596 + 8.45) / 52.833)
=0.207704 / 0.379422
=0.5474

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(-45.997 - -8.275 - -31.539) / 29.908
=-0.206734

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

MedAvail Holdings has a M-score of -4.01 suggests that the company is unlikely to be a manipulator.


MedAvail Holdings Beneish M-Score Related Terms

Thank you for viewing the detailed overview of MedAvail Holdings's Beneish M-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


MedAvail Holdings (MedAvail Holdings) Business Description

Traded in Other Exchanges
N/A
Address
4720 East Cotton Gin Loop, Suite 220, Phoenix, AZ, USA, 85040
MedAvail Holdings Inc is a telehealth-enabled pharmacy technology company. It operates in two segments: Retail Pharmacy Services and Pharmacy Technology. It generates the majority of revenue from the Retail Pharmacy Services segment, which is into operating SpotRx, a full-service retail pharmacy utilizing MedAvail's automated pharmacy technology, primarily servicing Medicare patients in the United States. The Pharmacy Technology segment develops and commercializes the MedCenter for direct sale or lease to third-party customers.
Executives
Ramona Seabaugh officer: Chief Financial Officer C/O MEDAVAIL TECHNOLOGIES INC., 6665 MILLCREEK DR, UNIT 1, MISSISSAUGA A6 L5N 5M4
Michael R Kramer director 3910 BRICKWAY BLVD, SANTA ROSA CA 95403
Paul D Johnson director 440 N BARRANCA AVE #3550, COVINA CA 91723
Glen D. Stettin director C/O EXPRESS SCRIPTS HOLDING COMPANY, ONE EXPRESS WAY, ST. LOUIS MO 63121
Mark Edward Doerr director, officer: Chief Executive Officer C/O MEDAVAIL TECHNOLOGIES INC., 6665 MILLCREEK DR, UNIT 1, MISSISSAUGA A6 L5N 5M4
Abg Wtt-medavail Ltd 10 percent owner 15 QUEENS ROAD CENTRAL, UNIT 3002-3004, 30TH FLOOR, GLOUCESTER TWR, THE LANDMARK, HONG KONG F4 0000000000
Redco Ii Master Fund, L.p. director, 10 percent owner ONE LETTERMAN DRIVE, BLDG D, STE D3-300, SAN FRANCISCO CA 94129
Alyeska Fund Gp, Llc 10 percent owner 77 WEST WACKER DRIVE, 7TH FLOOR, CHICAGO IL 60601
Alyeska Investment Group, Llc 10 percent owner 77 WEST WACKER DRIVE, 7TH FLOOR, CHICAGO IL 60601
Alyeska Investments, Llc 10 percent owner 77 WEST WACKER DRIVE, 7TH FLOOR, CHICAGO IL 60601
Anand Parekh 10 percent owner 77 WEST WACKER DRIVE, 7TH FLOOR, CHICAGO IL 60601
Alyeska Master Fund, L.p. 10 percent owner 77 WEST WACKER DRIVE, 7TH FLOOR, CHICAGO IL 60601
Alyeska Investment Group, L.p. 10 percent owner 77 WEST WACKER DRIVE, 7TH FLOOR, CHICAGO IL 60601
Steven Hess officer: Executive Vice President C/O MEDAVAIL TECHNOLOGIES INC., 6665 MILLCREEK DR, UNIT 1, MISSISSAUGA A6 L5N 5M4
Edwin Kilroy director, officer: Chief Executive Officer C/O MEDAVAIL TECHNOLOGIES INC., 6665 MILLCREEK DR, UNIT 1, MISSISSAUGA A6 L5N 5M4

MedAvail Holdings (MedAvail Holdings) Headlines

From GuruFocus

MedAvail Announces 1-for-50 Reverse Stock Split

By Marketwired 07-31-2023

Q4 2020 MedAvail Holdings Inc Earnings Call Transcript

By GuruFocus Research 02-07-2024

Q1 2023 MedAvail Holdings Inc Earnings Call Transcript

By GuruFocus Research 02-07-2024

MedAvail Announces Technology Partnership with Progressive Care, Inc

By Business Wire Business Wire 10-26-2022

Q4 2021 MedAvail Holdings Inc Earnings Call Transcript

By GuruFocus Research 02-07-2024

Q1 2022 MedAvail Holdings Inc Earnings Call Transcript

By GuruFocus Research 02-07-2024

Q3 2021 MedAvail Holdings Inc Earnings Call Transcript

By GuruFocus Research 02-07-2024

MedAvail announces Strategic Restructuring of Business to Focus on Profitability

By Stock market mentor Stock market mentor 01-19-2023

MedAvail to Report First Quarter 2023 Financial Results on May 15

By sperokesalga sperokesalga 05-15-2023